Our purpose
To deliver cutting-edge and proprietary technology in rapid diagnostics, leveraging artificial intelligence and data analytics to empower individuals with personalised and effective healthcare solutions, ultimately promoting health and wellness for all of humanity.
Our Mission
To transform the field of diagnostics and wellness by building an ecosystem that leverages the power of molecular pathology, microbiome immunology, health data, and artificial intelligence. We envision a future where every individual has access to personalised and accurate health information, enabling them to make informed decisions about their health and wellness. Our goal is to develop innovative solutions that not only diagnose but also prevent diseases, providing better health outcomes for all of humanity.
How we do it
Through collaboration with experts in these fields, we strive to push the boundaries of what is possible, driving progress and advancements that benefit society as a whole. We are committed to providing exceptional service to our clients and partners, utilizing our expertise and technology to deliver accurate and timely diagnostic information. At GO-Dx, we are dedicated to improving the health and well-being of individuals and communities worldwide, and we are proud to be at the forefront of this important work.
Products and Services
The Products include the products which the Company has rights to distribute in various Asian territories including
• “G’Nest Deluxe” and “G’Nest Premium” products manufactured and supplied by FEGO Biotech Pte Ltd;
and
• “C’Neuros” product manufactured and supplied by NGF Bioenterprise Pte Ltd (Products Range).
The Services include diagnostic testing and analysis services including:
• RNA mining/mapping & analytics platform
• Neurological and immunological precision medicine via proprietary genetic and epigenetic screening
Plus services currently in research and development phase, and planned for future commercialisation:
• miRNA-based early screening tests for various cancers and diagnostic platforms
• Chronic/infectious disease prediction via proprietary DNA profiling and fluorescence in situ hybridisation (FISH) platforms
• Liquid biopsy based diagnostics for cancers using NGS technology
• Al-enabled platform (Services Range)